The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Classical Swine Fever Vaccines Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Classical Swine Fever Vaccines Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2029

Publishing Date : Jul, 2023

License Type :
 

Report Code : 1397423

No of Pages : 118

Ask Your Query

Synopsis
The global Classical Swine Fever Vaccines market size was valued at USD 159.2 million in 2022 and is forecast to a readjusted size of USD 215.2 million by 2029 with a CAGR of 4.4% during review period.

It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of the genus Pestivirus of the family Flaviviridae, and is closely related to the viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV).
The global classical swine fever vaccine market is dominated by Winsun, Boehringer Ingelheim and CAHIC, with the top three manufacturers accounting for about 37% of the market share. Asia Pacific is the largest market for classical swine fever vaccines, with a market share of about 70%, followed by Europe with a market share of about 15%. Tissue Culture Origin is the main type, with a share about 66%. Market Sales is the main application, which holds a share about 95%.

The Global Info Research report includes an overview of the development of the Classical Swine Fever Vaccines industry chain, the market status of Government Tender (Tissue Culture Origin, Cell Line Origin), Market Sales (Tissue Culture Origin, Cell Line Origin), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Classical Swine Fever Vaccines.

Regionally, the report analyzes the Classical Swine Fever Vaccines markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Classical Swine Fever Vaccines market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:

The report presents comprehensive understanding of the Classical Swine Fever Vaccines market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Classical Swine Fever Vaccines industry.

The report involves analyzing the market at a macro level:

Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (M Doses), revenue generated, and market share of different by Source (e.g., Tissue Culture Origin, Cell Line Origin).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Classical Swine Fever Vaccines market.

Regional Analysis: The report involves examining the Classical Swine Fever Vaccines market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Classical Swine Fever Vaccines market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Classical Swine Fever Vaccines:

Company Analysis: Report covers individual Classical Swine Fever Vaccines manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Classical Swine Fever Vaccines This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Sales Channel (Government Tender, Market Sales).

Technology Analysis: Report covers specific technologies relevant to Classical Swine Fever Vaccines. It assesses the current state, advancements, and potential future developments in Classical Swine Fever Vaccines areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Classical Swine Fever Vaccines market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation

Classical Swine Fever Vaccines market is split by Source and by Sales Channel. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Source, and by Sales Channel in terms of volume and value.

Market segment by Source

  • Tissue Culture Origin
  • Cell Line Origin

Market segment by Sales Channel

  • Government Tender
  • Market Sales

Major players covered

  • WINSUN
  • Merck
  • CAHIC
  • Tecon
  • SPAH
  • Boehringer Ingelheim
  • Ceva
  • Harbin Veterinary Research Institute
  • Qilu Animal Health Products Factory
  • Ringpu Biology
  • DHN
  • CAVAC
  • Komipharm
  • Agrovet
  • Bioveta
  • Jinyu Bio-Technology
  • Institutul Pasteur
  • MVP

Market segment by region, regional analysis covers

  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Classical Swine Fever Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Classical Swine Fever Vaccines, with price, sales, revenue and global market share of Classical Swine Fever Vaccines from 2018 to 2023.
Chapter 3, the Classical Swine Fever Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Classical Swine Fever Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Source and sales channel, with sales market share and growth rate by source, sales channel, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Classical Swine Fever Vaccines market forecast, by regions, source and sales channel, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Classical Swine Fever Vaccines.
Chapter 14 and 15, to describe Classical Swine Fever Vaccines sales channel, distributors, customers, research findings and conclusion.

Index

1 Market Overview
1.1 Product Overview and Scope of Classical Swine Fever Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Source
1.3.1 Overview: Global Classical Swine Fever Vaccines Consumption Value by Source: 2018 Versus 2022 Versus 2029
1.3.2 Tissue Culture Origin
1.3.3 Cell Line Origin
1.4 Market Analysis by Sales Channel
1.4.1 Overview: Global Classical Swine Fever Vaccines Consumption Value by Sales Channel: 2018 Versus 2022 Versus 2029
1.4.2 Government Tender
1.4.3 Market Sales
1.5 Global Classical Swine Fever Vaccines Market Size & Forecast
1.5.1 Global Classical Swine Fever Vaccines Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Classical Swine Fever Vaccines Sales Quantity (2018-2029)
1.5.3 Global Classical Swine Fever Vaccines Average Price (2018-2029)
2 Manufacturers Profiles
2.1 WINSUN
2.1.1 WINSUN Details
2.1.2 WINSUN Major Business
2.1.3 WINSUN Classical Swine Fever Vaccines Product and Services
2.1.4 WINSUN Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 WINSUN Recent Developments/Updates
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Classical Swine Fever Vaccines Product and Services
2.2.4 Merck Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Merck Recent Developments/Updates
2.3 CAHIC
2.3.1 CAHIC Details
2.3.2 CAHIC Major Business
2.3.3 CAHIC Classical Swine Fever Vaccines Product and Services
2.3.4 CAHIC Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 CAHIC Recent Developments/Updates
2.4 Tecon
2.4.1 Tecon Details
2.4.2 Tecon Major Business
2.4.3 Tecon Classical Swine Fever Vaccines Product and Services
2.4.4 Tecon Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Tecon Recent Developments/Updates
2.5 SPAH
2.5.1 SPAH Details
2.5.2 SPAH Major Business
2.5.3 SPAH Classical Swine Fever Vaccines Product and Services
2.5.4 SPAH Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 SPAH Recent Developments/Updates
2.6 Boehringer Ingelheim
2.6.1 Boehringer Ingelheim Details
2.6.2 Boehringer Ingelheim Major Business
2.6.3 Boehringer Ingelheim Classical Swine Fever Vaccines Product and Services
2.6.4 Boehringer Ingelheim Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Boehringer Ingelheim Recent Developments/Updates
2.7 Ceva
2.7.1 Ceva Details
2.7.2 Ceva Major Business
2.7.3 Ceva Classical Swine Fever Vaccines Product and Services
2.7.4 Ceva Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Ceva Recent Developments/Updates
2.8 Harbin Veterinary Research Institute
2.8.1 Harbin Veterinary Research Institute Details
2.8.2 Harbin Veterinary Research Institute Major Business
2.8.3 Harbin Veterinary Research Institute Classical Swine Fever Vaccines Product and Services
2.8.4 Harbin Veterinary Research Institute Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Harbin Veterinary Research Institute Recent Developments/Updates
2.9 Qilu Animal Health Products Factory
2.9.1 Qilu Animal Health Products Factory Details
2.9.2 Qilu Animal Health Products Factory Major Business
2.9.3 Qilu Animal Health Products Factory Classical Swine Fever Vaccines Product and Services
2.9.4 Qilu Animal Health Products Factory Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Qilu Animal Health Products Factory Recent Developments/Updates
2.10 Ringpu Biology
2.10.1 Ringpu Biology Details
2.10.2 Ringpu Biology Major Business
2.10.3 Ringpu Biology Classical Swine Fever Vaccines Product and Services
2.10.4 Ringpu Biology Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Ringpu Biology Recent Developments/Updates
2.11 DHN
2.11.1 DHN Details
2.11.2 DHN Major Business
2.11.3 DHN Classical Swine Fever Vaccines Product and Services
2.11.4 DHN Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 DHN Recent Developments/Updates
2.12 CAVAC
2.12.1 CAVAC Details
2.12.2 CAVAC Major Business
2.12.3 CAVAC Classical Swine Fever Vaccines Product and Services
2.12.4 CAVAC Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 CAVAC Recent Developments/Updates
2.13 Komipharm
2.13.1 Komipharm Details
2.13.2 Komipharm Major Business
2.13.3 Komipharm Classical Swine Fever Vaccines Product and Services
2.13.4 Komipharm Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Komipharm Recent Developments/Updates
2.14 Agrovet
2.14.1 Agrovet Details
2.14.2 Agrovet Major Business
2.14.3 Agrovet Classical Swine Fever Vaccines Product and Services
2.14.4 Agrovet Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Agrovet Recent Developments/Updates
2.15 Bioveta
2.15.1 Bioveta Details
2.15.2 Bioveta Major Business
2.15.3 Bioveta Classical Swine Fever Vaccines Product and Services
2.15.4 Bioveta Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Bioveta Recent Developments/Updates
2.16 Jinyu Bio-Technology
2.16.1 Jinyu Bio-Technology Details
2.16.2 Jinyu Bio-Technology Major Business
2.16.3 Jinyu Bio-Technology Classical Swine Fever Vaccines Product and Services
2.16.4 Jinyu Bio-Technology Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Jinyu Bio-Technology Recent Developments/Updates
2.17 Institutul Pasteur
2.17.1 Institutul Pasteur Details
2.17.2 Institutul Pasteur Major Business
2.17.3 Institutul Pasteur Classical Swine Fever Vaccines Product and Services
2.17.4 Institutul Pasteur Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Institutul Pasteur Recent Developments/Updates
2.18 MVP
2.18.1 MVP Details
2.18.2 MVP Major Business
2.18.3 MVP Classical Swine Fever Vaccines Product and Services
2.18.4 MVP Classical Swine Fever Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 MVP Recent Developments/Updates
3 Competitive Environment: Classical Swine Fever Vaccines by Manufacturer
3.1 Global Classical Swine Fever Vaccines Sales Quantity by Manufacturer (2018-2023)
3.2 Global Classical Swine Fever Vaccines Revenue by Manufacturer (2018-2023)
3.3 Global Classical Swine Fever Vaccines Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Classical Swine Fever Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Classical Swine Fever Vaccines Manufacturer Market Share in 2022
3.4.2 Top 6 Classical Swine Fever Vaccines Manufacturer Market Share in 2022
3.5 Classical Swine Fever Vaccines Market: Overall Company Footprint Analysis
3.5.1 Classical Swine Fever Vaccines Market: Region Footprint
3.5.2 Classical Swine Fever Vaccines Market: Company Product Type Footprint
3.5.3 Classical Swine Fever Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Classical Swine Fever Vaccines Market Size by Region
4.1.1 Global Classical Swine Fever Vaccines Sales Quantity by Region (2018-2029)
4.1.2 Global Classical Swine Fever Vaccines Consumption Value by Region (2018-2029)
4.1.3 Global Classical Swine Fever Vaccines Average Price by Region (2018-2029)
4.2 North America Classical Swine Fever Vaccines Consumption Value (2018-2029)
4.3 Europe Classical Swine Fever Vaccines Consumption Value (2018-2029)
4.4 Asia-Pacific Classical Swine Fever Vaccines Consumption Value (2018-2029)
4.5 South America Classical Swine Fever Vaccines Consumption Value (2018-2029)
4.6 Middle East and Africa Classical Swine Fever Vaccines Consumption Value (2018-2029)
5 Market Segment by Source
5.1 Global Classical Swine Fever Vaccines Sales Quantity by Source (2018-2029)
5.2 Global Classical Swine Fever Vaccines Consumption Value by Source (2018-2029)
5.3 Global Classical Swine Fever Vaccines Average Price by Source (2018-2029)
6 Market Segment by Sales Channel
6.1 Global Classical Swine Fever Vaccines Sales Quantity by Sales Channel (2018-2029)
6.2 Global Classical Swine Fever Vaccines Consumption Value by Sales Channel (2018-2029)
6.3 Global Classical Swine Fever Vaccines Average Price by Sales Channel (2018-2029)
7 North America
7.1 North America Classical Swine Fever Vaccines Sales Quantity by Source (2018-2029)
7.2 North America Classical Swine Fever Vaccines Sales Quantity by Sales Channel (2018-2029)
7.3 North America Classical Swine Fever Vaccines Market Size by Country
7.3.1 North America Classical Swine Fever Vaccines Sales Quantity by Country (2018-2029)
7.3.2 North America Classical Swine Fever Vaccines Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Classical Swine Fever Vaccines Sales Quantity by Source (2018-2029)
8.2 Europe Classical Swine Fever Vaccines Sales Quantity by Sales Channel (2018-2029)
8.3 Europe Classical Swine Fever Vaccines Market Size by Country
8.3.1 Europe Classical Swine Fever Vaccines Sales Quantity by Country (2018-2029)
8.3.2 Europe Classical Swine Fever Vaccines Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Classical Swine Fever Vaccines Sales Quantity by Source (2018-2029)
9.2 Asia-Pacific Classical Swine Fever Vaccines Sales Quantity by Sales Channel (2018-2029)
9.3 Asia-Pacific Classical Swine Fever Vaccines Market Size by Region
9.3.1 Asia-Pacific Classical Swine Fever Vaccines Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Classical Swine Fever Vaccines Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Classical Swine Fever Vaccines Sales Quantity by Source (2018-2029)
10.2 South America Classical Swine Fever Vaccines Sales Quantity by Sales Channel (2018-2029)
10.3 South America Classical Swine Fever Vaccines Market Size by Country
10.3.1 South America Classical Swine Fever Vaccines Sales Quantity by Country (2018-2029)
10.3.2 South America Classical Swine Fever Vaccines Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Classical Swine Fever Vaccines Sales Quantity by Source (2018-2029)
11.2 Middle East & Africa Classical Swine Fever Vaccines Sales Quantity by Sales Channel (2018-2029)
11.3 Middle East & Africa Classical Swine Fever Vaccines Market Size by Country
11.3.1 Middle East & Africa Classical Swine Fever Vaccines Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Classical Swine Fever Vaccines Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Classical Swine Fever Vaccines Market Drivers
12.2 Classical Swine Fever Vaccines Market Restraints
12.3 Classical Swine Fever Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Classical Swine Fever Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Classical Swine Fever Vaccines
13.3 Classical Swine Fever Vaccines Production Process
13.4 Classical Swine Fever Vaccines Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Classical Swine Fever Vaccines Typical Distributors
14.3 Classical Swine Fever Vaccines Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

Published By : GlobalInfoResearch

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock